Results 131 to 140 of about 6,272,020 (179)

Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab. [PDF]

open access: yesBMJ Neurol Open
Høgestøl EA   +13 more
europepmc   +1 more source

Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023-2025. [PDF]

open access: yesInfluenza Other Respir Viruses
Evans D   +14 more
europepmc   +1 more source

Associations of common infections with frailty and mortality in two UK cohort studies. [PDF]

open access: yesJ Gerontol A Biol Sci Med Sci
Smeeth D   +7 more
europepmc   +1 more source

Progressive multifocal leukoencephalopathy as a rare first manifestation of AIDS: case report. [PDF]

open access: yesPostep Psychiatr Neurol
Kuls-Oszmaniec A   +5 more
europepmc   +1 more source

Comparative evaluation of STRATIFY JCV™ and IMMUNOWELL™ assays for anti-JCV antibody detection in natalizumab-treated RRMS patients. [PDF]

open access: yesTher Adv Neurol Disord
Chisari CG   +7 more
europepmc   +1 more source

Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma. [PDF]

open access: yesFuture Oncol
Johnson NA   +19 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy